This drug is going to be a Tamiflu or Relenza. When relenza was...

This drug is going to be a Tamiflu or Relenza. When relenza was released it climbed to around $10 and then fell due to bad marketing.
With this one it will be easy to market (it will sell itself).

Once this trial is finished then it will be on to the next one quickly. Just think there is potential to make ten times the curent value of the share in around 2 years.

This sort of thing comes around once in a lifetime.

Look at the price rising. I predict around $2 prior to announcement.